Shuliang Chen
-
- Innovation and Socioeconomic Development 3
- Virology top 2%
- HIV Research and Treatment 9
- Aging top 10%
- Molecular Biology top 10%
- CRISPR and Genetic Engineering 13
- RNA Interference and Gene Delivery 4
- Ubiquitin and proteasome pathways 4
- Immunology top 10%
- interferon and immune responses 8
-
- Mosquito-borne diseases and control 5
-
- Cancer, Hypoxia, and Metabolism 4
- Journals
- Retrovirology (3 papers)Scientific Reports (2 papers)Journal of Cellular Biochemistry (2 papers)
- Partner nations
- ChinaUnited StatesFinland
In The Last Decade
Shuliang Chen
33 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 88
- Business and International Management 149
- Virology 263
- Aging 26
- Molecular Biology 1.0k
- Immunology 278
Countries citing papers authored by Shuliang Chen
This map shows the geographic impact of Shuliang Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuliang Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuliang Chen more than expected).
Fields of papers citing papers by Shuliang Chen
This network shows the impact of papers produced by Shuliang Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuliang Chen. The network helps show where Shuliang Chen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Shuliang Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 2 | |
| 3 | 2023 | 4 | |
| 4 | 2022 | 17 | |
| 5 | 2022 | 6 | |
| 6 | 2020 | 95 | |
| 7 | 2020 | 77 | |
| 8 | 2020 | 22 | |
| 9 | 2019 | 36 | |
| 10 | 2018 | 30 | |
| 11 | 2018 | 37 | |
| 12 | 2017 | 37 | |
| 13 | 2017 | 15 | |
| 14 | 2017 | 127 | |
| 15 | 2016 | 14 | |
| 16 | 2015 | 170 | |
| 17 | 2015 | 12 | |
| 18 | 2015 | 22 | |
| 19 | 2013 | 16 | |
| 20 | 2013 | 22 |
About Shuliang Chen
Shuliang Chen is a scholar working on Virology, Business and International Management, Immunology, Cancer Research and Molecular Biology, having authored 33 papers that have together received 1.4k indexed citations. Recurring topics across this work include CRISPR and Genetic Engineering (13 papers), HIV Research and Treatment (9 papers), interferon and immune responses (8 papers), Mosquito-borne diseases and control (5 papers), Cancer, Hypoxia, and Metabolism (4 papers), RNA Interference and Gene Delivery (4 papers), Ubiquitin and proteasome pathways (4 papers) and Innovation and Socioeconomic Development (3 papers). The work is most often cited by research in Business and International Management (149 citations), Virology (263 citations), Aging (26 citations), Molecular Biology (1.0k citations) and Immunology (278 citations). Shuliang Chen has collaborated with scholars based in China, United States and Finland. Frequent co-authors include Deyin Guo, Qiaoqiao Xiao, Yu Chen, Xiao Yu, Panpan Hou, Chunmei Li, Wei Hou, Li Wu, Ruidong Hao and Xing Liu. Their work appears in journals such as Retrovirology, Scientific Reports, Journal of Cellular Biochemistry, Biochemical and Biophysical Research Communications and Cell & Bioscience.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.